 NEWARK, Calif., Feb. 10, 2022 GLOBE NEWSWIRE -- CymaBay Therapeutics, Inc. NASDAQ: CBAY, a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that management will participate in two virtual investor conferences including the 11th Annual SVB Leerink Global Healthcare Conference taking place February 14-18, 2022 and Oppenheimers 32nd Annual Healthcare Conference taking place March 15-16, 2022. 